Outpace Bio logo

Outpace Bio

Seattle, WA

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

outpacebio.com

Company Details

Founded

2020

Employees

Between 20 - 100 employees

Raised

$199,000,000

Headquarters Location

Seattle, WA

Public

No

Acquired

No

CEO

Marc LajoieMarc Lajoie

Founders

Scott Boyken
Scott Boyken
Marc Lajoie
Marc Lajoie

Company Collections

These are collections Outpace Bio is a part of. Click on the collection name to view similar companies.

Current Job Listings

Listing 0 of 2 job openings

    Outpace Bio Headquarters Location

    500 Fairview Ave N suite 560, Seattle, WA 98109

    Total Amount Raised: $199,000,000

    Outpace Bio Funding Rounds

    • Series B

      $144,000,000

      Series B Investors

      RA Capital Management
      Surveyor Capital
      Bristol-Myers Squibb Company
      Sheatree Capital
      Playground Global
      WRF Capital
      Black Opal Ventures
      Alexandria Venture Investments
      Civilization Ventures
      Abstract
      Sahsen Ventures
      Breton Capital Management
      Mubadala Capital
      Artis Ventures
      Qatar Investment Authority
      Qiming Venture Partners
    • Series A

      $25,000,000

      Series A Investors

      Playground Global
      Sahsen Ventures
      Artis Ventures
      Bristol-Myers Squibb Company
      Mubadala Capital Ventures
      Civilization Ventures
    • Series A

      $30,000,000

      Series A Investors

      Artis Ventures
      Lyell Immunopharma
      Abstract
      Civilization Ventures
      Sahsen Ventures
      Playground Global
      Mubadala Capital Ventures
      WRF Capital
      Washington Research Licensing Foundation (WRF)
    Funding info provided by Diffbot.

    Outpace Bio Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Outpace Bio.

    Recent reviews